Trends in Formulation for Highly Potent Drugs

When considering manufacturing and the growth of drug formulation, it is evident that there has been change and many new advancements introduced to make processes more efficient. However, in terms of formulating highly potent drugs, their specific release requirements and poor aqueous bioavailability make them challenging to produce and analyze (1).

Although there may be difficulties seen with analytical challenges, the strength of oral solid dosage (OSD) forms and the manufacture of all pharmaceutical finished dosage forms continues to be prominent. According to research, the OSD market outlook is expected to continue growing and have low production costs, even with the knowledge of how unpredictable formulation may become (2).

Pharmaceutical Technology® discussed new formulation trends with Shailesh Vengurlekar, senior VP of Quailty and Regulatory Affairs at LGM Pharma, and how the industry can go forward with these advancements, despite any challenges that may arise.

Read this article in the Trends in Formulation 2023 eBook

About the author

Jill Murphy is Editor at Pharmaceutical Technology.

Article details

Pharmaceutical Technology

eBook: Trends in Formulation

October 2023

Pages: 12-14

Citation

When referring to this article, please cite it as J. Murphy, "Trends in Formulation for Highly Potent Drugs," Pharmaceutical Technology's Trends in Formulation eBook (October 2023).